Amarantus Bioscience Holdings Inc (AMBS)

[Voices of Reason]

Regarding the 10Q and further to my earlier comments (http://investorshub.advfn.com/boards/read_msg.aspx?message_id=80755298 ), the dilution continues:

From the latest 10Q, the O/S shares increased from 108 million to 224 million

There remains a large number of convertible notes remaining, too numerous to mention here, but can be found at: http://www.otcmarkets.com/edgar/GetFilingHtml?FilingID=8926855

At a meeting held November 13 th , 2012, the Board of Directors approved an increase in the authorized common shares of the corporation from 250,000,000 to 1,000,000,000 (that's 1 Billion!)

At a meeting held November 13 th , 2012, the Board of Directors approved an increase in the 2008 Stock Option plan from 18,242,127 common shares to 50,000,000 common shares.

In November, 2012 the Board of Directors granted 1,250,000 options to purchase Series B stock to certain officers and directors

On November 16 th , 2012, the Company became aware of a lawsuit filed by Alpha Capital Ansalt (“Alpha”) in Federal court related to Alpha’s April 24 th , 2012 assignment of a non-convertible promissory note in the principle amount of $150,000 dated October 4 th , 2011 from Dr. Samuel Herschkowitz, a former advisor to the Company.

In November 2012, the Company issued a Convertible Promissory Note to an Dominion Capital, LLC (the “Investor”) in the principal amount of $600,000.